John F Dillon Selected Research

TBE 31

3/2018

Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John F Dillon Research Topics

Disease

22	Hepatitis C 08/2022 - 05/2011
20	Infections 01/2021 - 02/2013
16	Fibrosis (Cirrhosis) 01/2022 - 01/2010
12	Liver Diseases (Liver Disease) 01/2022 - 08/2008
8	Reinfection 08/2022 - 09/2015
6	Non-alcoholic Fatty Liver Disease 01/2022 - 04/2011
3	Neoplasms (Cancer) 01/2022 - 05/2006
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2013
3	Liver Cirrhosis (Hepatic Cirrhosis) 11/2021 - 01/2018
3	Blister (Bulla) 10/2020 - 01/2018
3	Chronic Hepatitis C 01/2019 - 06/2012
3	Chemical and Drug Induced Liver Injury 01/2019 - 07/2009
3	Insulin Resistance 03/2018 - 01/2012
2	End Stage Liver Disease 01/2022 - 11/2015
2	Substance-Related Disorders (Drug Abuse) 01/2021 - 01/2020
2	Fatty Liver 03/2018 - 09/2014
2	Inflammation (Inflammations) 03/2018 - 01/2010
2	Liver Neoplasms (Liver Cancer) 01/2018 - 01/2017
2	Hepatic Encephalopathy 10/2017 - 01/2016
2	Adenocarcinoma 07/2007 - 01/2003
2	Poisoning 10/2002 - 06/2002
1	Thrombocytosis (Thrombocythemia) 01/2022
1	Alcoholism (Alcohol Abuse) 01/2022
1	Mental Disorders (Mental Disorder) 01/2021
1	Alcoholic Fatty Liver 04/2020
1	Rhabdomyolysis 01/2018
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Disease Susceptibility (Diathesis) 01/2017
1	Thrombocytopenia (Thrombopenia) 04/2016
1	Hepatitis B 01/2016
1	Persistent Infection 11/2015
1	Needlestick Injuries (Needlestick Injury) 11/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2015
1	Obesity 01/2012
1	Morbid Obesity 01/2012
1	Type 2 Diabetes Mellitus (MODY) 01/2012
1	Heart Diseases (Heart Disease) 01/2012
1	Kidney Neoplasms (Kidney Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

21	Pharmaceutical PreparationsIBA 01/2022 - 05/2011
20	Antiviral Agents (Antivirals)IBA 08/2022 - 12/2014
12	InterferonsIBA 01/2022 - 06/2012
6	EnzymesIBA 01/2022 - 01/2003
4	SofosbuvirIBA 10/2020 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 04/2020 - 04/2011
3	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2016
3	glecaprevir and pibrentasvirIBA 01/2021 - 01/2019
3	Ribavirin (Virazole)FDA LinkGeneric 10/2020 - 06/2012
3	velpatasvirIBA 10/2020 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2010
2	Alkaline PhosphataseIBA 01/2022 - 01/2012
2	Illicit Drugs (Recreational Drugs)IBA 01/2020 - 01/2019
2	Opiate AlkaloidsIBA 01/2019 - 08/2016
2	Floxacillin (Flucloxacillin)IBA 01/2019 - 07/2009
2	LipidsIBA 03/2018 - 01/2012
2	Rifaximin (L 105)FDA Link 10/2017 - 01/2016
2	Transaminases (Aminotransferases)IBA 01/2012 - 08/2009
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2008 - 05/2006
2	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2002 - 06/2002
1	Basic-Leucine Zipper Transcription FactorsIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	AntigensIBA 01/2022
1	dasabuvirIBA 10/2020
1	Ritonavir (Norvir)FDA Link 10/2020
1	paritaprevirIBA 10/2020
1	Opioid Analgesics (Opioids)IBA 10/2020
1	ombitasvirIBA 10/2020
1	Uric Acid (Urate)IBA 04/2020
1	sofosbuvir drug combination ledipasvirIBA 01/2020
1	daclatasvirIBA 01/2020
1	EpitopesIBA 01/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	Insulin (Novolin)FDA Link 03/2018
1	Lipoproteins (Lipoprotein)IBA 03/2018
1	Glucose (Dextrose)FDA LinkGeneric 03/2018
1	TBE 31IBA 03/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2018
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2018
1	imidazoloneIBA 01/2018
1	ImmunosorbentsIBA 01/2018
1	Advanced Glycation End ProductsIBA 01/2018
1	Hepatitis C AntibodiesIBA 11/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2015
1	ProteomeIBA 10/2014
1	Vitamin D-Binding ProteinIBA 10/2014
1	Insulin-Like Growth Factor Binding Protein 3IBA 10/2014
1	ApolipoproteinsIBA 10/2014
1	NF-E2 Transcription FactorIBA 09/2014
1	Hepatitis B e AntigensIBA 04/2013
1	AlbuminsIBA 01/2012
1	BilirubinIBA 01/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2012

Therapy/Procedure

19	Therapeutics 01/2022 - 08/2008
5	Opiate Substitution Treatment 10/2020 - 01/2018
2	Length of Stay 01/2022 - 01/2010
2	Duration of Therapy 01/2021 - 12/2014
1	Drug Therapy (Chemotherapy) 01/2019
1	Tattooing 11/2015
1	Blood Transfusion (Blood Transfusions) 02/2013
1	Bariatric Surgery 01/2012